Peptic Ulcer Drugs Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Peptic Ulcer Drugs Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2024 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overviews
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
      3. Global Healthcare Spending Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Drug Adoption Analysis
   2. Value Chain Analysis
      1. List of End-user/Marketplaces
         1. Retail
         2. E-Commerce
      2. List of Distribution Channel (Industry)
   3. Key Deals and Mergers
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Global Peptic Ulcer Drugs Market Outlook
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2032
   3. Global Peptic Ulcer Drugs Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
         1. Proton Pump Inhibitors
         2. Potassium-Competitive Acid Blockers (P-CABs)
         3. Antacids
         4. H2- Antagonists
         5. Antibiotics
         6. Ulcer Protective
      4. Market Attractiveness Analysis: Product
   4. Global Peptic Ulcer Drugs Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
         1. Gastritis
         2. Gastric Ulcers
         3. Duodenal Ulcers
         4. Gastroesophageal Reflux Disease (GERD) 
      4. Market Attractiveness Analysis: Indication
   5. Global Peptic Ulcer Drugs Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
         1. Hospital Pharmacies
         2. Private Clinics
         3. Drug Stores
         4. Retail Pharmacies
         5. E-Commerce   
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Peptic Ulcer Drugs Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2023
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Peptic Ulcer Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Proton Pump Inhibitors
      2. Potassium-Competitive Acid Blockers (P-CABs)
      3. Antacids
      4. H2- Antagonists
      5. Antibiotics
      6. Ulcer Protective
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Gastritis
      2. Gastric Ulcers
      3. Duodenal Ulcers
      4. Gastroesophageal Reflux Disease (GERD)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Private Clinics
      3. Drug Stores
      4. Retail Pharmacies
      5. E-Commerce
   7. Market Attractiveness Analysis
7. Europe Peptic Ulcer Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Proton Pump Inhibitors
      2. Potassium-Competitive Acid Blockers (P-CABs)
      3. Antacids
      4. H2- Antagonists
      5. Antibiotics
      6. Ulcer Protective
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Gastritis
      2. Gastric Ulcers
      3. Duodenal Ulcers
      4. Gastroesophageal Reflux Disease (GERD)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Private Clinics
      3. Drug Stores
      4. Retail Pharmacies
      5. E-Commerce
   7. Market Attractiveness Analysis
8. East Asia Peptic Ulcer Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Proton Pump Inhibitors
      2. Potassium-Competitive Acid Blockers (P-CABs)
      3. Antacids
      4. H2- Antagonists
      5. Antibiotics
      6. Ulcer Protective
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Gastritis
      2. Gastric Ulcers
      3. Duodenal Ulcers
      4. Gastroesophageal Reflux Disease (GERD)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Private Clinics
      3. Drug Stores
      4. Retail Pharmacies
      5. E-Commerce
   7. Market Attractiveness Analysis
9. South Asia and Oceania Peptic Ulcer Drugs Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
      1. Proton Pump Inhibitors
      2. Potassium-Competitive Acid Blockers (P-CABs)
      3. Antacids
      4. H2- Antagonists
      5. Antibiotics
      6. Ulcer Protective
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
      1. Gastritis
      2. Gastric Ulcers
      3. Duodenal Ulcers
      4. Gastroesophageal Reflux Disease (GERD)
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Private Clinics
      3. Drug Stores
      4. Retail Pharmacies
      5. E-Commerce
   7. Market Attractiveness Analysis
10. Latin America Peptic Ulcer Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       1. By Country
       2. By Product
       3. By Indication
       4. By Distribution Channel
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
       1. Proton Pump Inhibitors
       2. Potassium-Competitive Acid Blockers (P-CABs)
       3. Antacids
       4. H2- Antagonists
       5. Antibiotics
       6. Ulcer Protective
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
       1. Gastritis
       2. Gastric Ulcers
       3. Duodenal Ulcers
       4. Gastroesophageal Reflux Disease (GERD)
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
       1. Hospital Pharmacies
       2. Private Clinics
       3. Drug Stores
       4. Retail Pharmacies
       5. E-Commerce
    7. Market Attractiveness Analysis
11. Middle East & Africa Peptic Ulcer Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       1. By Country
       2. By Product
       3. By Indication
       4. By Distribution Channel
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 - 2032
       1. Proton Pump Inhibitors
       2. Potassium-Competitive Acid Blockers (P-CABs)
       3. Antacids
       4. H2- Antagonists
       5. Antibiotics
       6. Ulcer Protective
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 - 2032
       1. Gastritis
       2. Gastric Ulcers
       3. Duodenal Ulcers
       4. Gastroesophageal Reflux Disease (GERD)
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
       1. Hospital Pharmacies
       2. Private Clinics
       3. Drug Stores
       4. Retail Pharmacies
       5. E-Commerce
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Daewoong Pharmaceutical Co., Ltd.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Takeda Pharmaceutical Company Limited
       3. Pfizer Inc.
       4. Abbott Laboratories
       5. AstraZeneca plc.
       6. Cadila Healthcare Ltd.
       7. Boehringer Ingelheim GmbH
       8. Eisai Co. Ltd.
       9. Yuhan Corporation
       10. GlaxoSmithKline plc.
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations